JANUS HENDERSON GROUP PLC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 258 filers reported holding HAEMONETICS CORP in Q4 2021. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.

Quarter-by-quarter ownership
JANUS HENDERSON GROUP PLC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2023$2,037,719
+5.2%
22,755
+0.0%
0.00%0.0%
Q2 2023$1,936,346
+2.8%
22,751
-0.1%
0.00%0.0%
Q1 2023$1,884,484
+128.4%
22,780
+117.1%
0.00%0.0%
Q4 2022$825,122
+24.8%
10,493
+17.6%
0.00%
Q3 2022$661,000
-1.5%
8,924
-13.4%
0.00%
Q2 2022$671,000
+2.9%
10,302
-0.2%
0.00%
Q1 2022$652,000
-97.2%
10,320
-97.7%
0.00%
-100.0%
Q4 2021$23,543,000
-72.3%
443,865
-63.2%
0.01%
-73.0%
Q3 2021$85,039,000
+84.4%
1,204,684
+74.1%
0.04%
+85.0%
Q2 2021$46,120,000692,0720.02%
Other shareholders
HAEMONETICS CORP shareholders Q4 2021
NameSharesValueWeighting ↓
Millrace Asset Group, Inc. 19,264$1,7262.13%
Parkman Healthcare Partners LLC 88,962$7,969,2161.46%
HEARTLAND ADVISORS INC 256,414$24,435,2741.37%
Riverwater Partners LLC 15,553$1,393,2381.27%
KINGDON CAPITAL MANAGEMENT, L.L.C. 111,100$9,952,3381.15%
Lisanti Capital Growth, LLC 78,425$7,025,3121.11%
Aristotle Capital Boston, LLC 311,666$27,919,0540.90%
ROYCE & ASSOCIATES LP 947,550$84,881,5290.86%
CHASE INVESTMENT COUNSEL CORP 18,770$1,6810.84%
Virtus Investment Advisers, Inc. 13,662$1,223,8420.83%
View complete list of HAEMONETICS CORP shareholders